original ) (raw )Idiopathic Macular Telangiectasia Type 1 treated with Intravitreal Ranibizumab and Laser Photocoagulation
lilianne duarte
Vision Pan-America, The Pan-American Journal of Ophthalmology, 2015
View PDFchevron_right
Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia
Irfan Perente
Turkish journal of ophthalmology, 2017
View PDFchevron_right
Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia
Ekta Rishi
Graefes Archive for Clinical and Experimental Ophthalmology, 2008
View PDFchevron_right
Idiopathic Juxtafoveal Retinal Telangiectasis
Tony Ko
Ophthalmology, 2006
View PDFchevron_right
Efficacy of Anti–Vascular Endothelial Growth Factor Therapy in Subretinal Neovascularization Secondary to Macular Telangiectasia Type 2
Mudit Tyagi
Retina, 2012
View PDFchevron_right
A 1-YEAR Retrospective Review of Ranibizumab for Naïve Nonsubfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Luis Arias
Retina, 2009
View PDFchevron_right
Triple Therapy Management of Macular Telangiectasia
Dr Hammad Nasti
Delhi Journal of Ophthalmology, 2015
View PDFchevron_right
Bilateral choroidal neovascularization response to unilateral intravitreal Ranibizumab injection in a patient with angioid streaks
Beatriz Takahashi
Revista Brasileira de Oftalmologia, 2013
View PDFchevron_right
Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological Myopia
Rufino Silva
Ophthalmologica, 2011
View PDFchevron_right
Ranibizumab Treatment for Choroidal Neovascularization Secondary to Causes Other than Age-Related Macular Degeneration with Good Baseline Visual Acuity
Muhammet Erol
Seminars in Ophthalmology, 2014
View PDFchevron_right
Ranibizumab in the treatment of choroidal neovascularisation due to age-related macular degeneration: an optical coherence tomography and multifocal electroretinography study
Luis Arias
Clinical and Experimental Optometry, 2011
View PDFchevron_right
Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia
Eric Sigler
Graefe's Archive for Clinical and Experimental Ophthalmology, 2013
View PDFchevron_right
COMBINED FLUORESCEIN ANGIOGRAPHY AND SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGING OF CLASSIC CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION BEFORE AND AFTER INTRAVITREAL RANIBIZUMAB INJECTIONS
Florence Coscas
Retina, 2012
View PDFchevron_right
The effect of intravitreal ranibizumab injection on visual acuity and central macular thickness in subgroups with neovascular age-related macular degeneration
M. Leonardo
Journal of Experimental and Clinical Medicine, 2013
View PDFchevron_right
Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
Joan Monés , L. Amselem
Eye, 2009
View PDFchevron_right
Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review
Kenneth Eng , Taha Bandukwala , Carol Schwartz
Canadian Journal of Ophthalmology Journal Canadien D Ophtalmologie, 2010
View PDFchevron_right
Polypoidal Choroidal Vasculopathy Masquerading as Neovascular Age-Related Macular Degeneration Refractory to Ranibizumab
DENNIS ORLOCK
American Journal of Ophthalmology, 2010
View PDFchevron_right
Super-dose Anti-VEGF (SAVE) Trial: 2.0 mg Intravitreal Ranibizumab for Recalcitrant Neovascular Macular Degeneration–Primary End Point
James Major
Ophthalmology, 2013
View PDFchevron_right
Choroidal neovascularization associated with adult‐onset vitelliform dystrophy treated with intravitreal ranibizumab
Lee Jampol
Acta Ophthalmologica, 2010
View PDFchevron_right
Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Endogenous Endophthalmitis
Sidra Zafar
The Kaohsiung Journal of Medical Sciences, 2009
View PDFchevron_right
Fluorescein Angiography Versus Optical Coherence Tomography Angiography in Macular Telangiectasia Type I Treated With Bevacizumab Therapy
Raquel Goldhardt
Ophthalmic Surgery, Lasers and Imaging Retina, 2017
View PDFchevron_right
Intravitreal ranibizumab for choroidal neovascularization secondary to angiod streaks. Comparison of the 12 and 24-month results of treatment in treatment-naïve eyes
Ilias Georgalas
European review for medical and pharmacological sciences, 2016
View PDFchevron_right
Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy
Nathalie Puche , Gabriel Coscas , Agnes Glacet-bernard
Acta Ophthalmologica, 2010
View PDFchevron_right
Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
Tanishq Sharma
Cureus, 2021
View PDFchevron_right
Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion
Richard Spaide
American Journal of Ophthalmology, 2009
View PDFchevron_right